Mucosal-associated invariant T (MAIT) cells are a well-characterized innate-like T cell population abundant in the human liver, peripheral tissues and blood. MAIT cells serve in the first line of defense against infections, through engagement of their T cell receptor, which recognizes microbial metabolites presented on MR1, and through cytokine-mediated triggering. Typically, they show a quiescent memory phenotype but can undergo rapid upregulation of effector functions including cytolysis upon stimulation. T cells profoundly change their cellular metabolism during their maturation and activation. We sought to determine how MAIT cell metabolism may facilitate both the longterm memory phase in tissue and the transition to rapid effector function. Here, we show, by flow cytometric metabolism assays and extracellular flux analysis that, despite an effector-memory profile, human MAIT cells are metabolically quiescent in a resting state comparable to na€ ıve and central memory T cells. Upon stimulation, they rapidly increase uptake of glucose and show a concomitant upregulation of the effector molecules notably granzyme B, which is impaired by inhibition of glycolysis with 2-deoxyglucose. These findings suggest that MAIT cells share some metabolic characteristics of both resting and effector T cell subsets, with a rapid transition upon triggering. Metabolic programming of this cell type may be of interest in understanding and modulating their function in infectious diseases and cancer.
INTRODUCTION

Mucosal-associated invariant T (MAIT) cells constitute a population of innate-like T cells abundant in humans.
They make up to 1-10% of peripheral T cells and up to 50% of hepatic T cells. 1 They are also present at mucosal surfaces 2 and have been shown to play important roles in settings of bacterial 3 and viral infection 4 as well as cancer. 5 They express a semi-invariant T cell receptor (Va7.2) on their cellular surface, 6 through which they recognize ligands presented by the nonclassical MHC class Ib molecule MR-1 (MHC-class I related protein 1). 2 MR-1 binds metabolites of the riboflavin metabolism pathway, found in certain bacteria such as Escherichia coli. Combined staining for both T cell receptor (TCR) Va7.2 (or MR1-ligand tetramer) and CD161 allows MAIT cells to be distinguished from other T cell populations.
They possess an effector-memory phenotype, 1 do not express CCR7 and are either CD45RA positive or negative. Upon stimulation through TCR ligation or by cytokine-driven activation (IL-12 and IL-18), 7 they rapidly carry out their effector functions by secreting IFN-c, IL-17, granzyme B, perforin and TNF-a. 1, [7] [8] [9] Due to their location in tissues frequently exposed to pathogens (blood, intestine and liver), they serve as a rapid bridging response. Immune cells differ in their cellular metabolism according to their activation state. Recognition of cognate antigen during an immune response by na€ ıve T cells switches them from a metabolically quiescent state, preferentially using oxidative phosphorylation for ATP production, to a more active state, predominantly reliant upon the use of aerobic glycolysis. 10 Once the antigen is cleared, "metabolically primed" memory T cells revert to oxidative phosphorylation and fatty acid oxidation. 11 Similarly, innate responses show preferential use of glycolysis and the utilization of the pentose phosphate pathway in acute responses. 12 Due to their specific localization and their dual mode of action-long term surveillance versus rapid activation-MAIT cells need to adapt their metabolism accordingly. In this study, we provide the first evidence of metabolic properties of MAIT 16 Changes in oxygen consumption rate upon the addition of carbonyl cyanide-p-trifluoromethoxyphenylhydrazone, an agent that disrupts ATP synthesis by blocking the proton gradient across the mitochondrial membrane indicate that MAIT cells have a low maximal respiratory capacity (Maximal oxygen consumption rate; Figure 1a ). This results in much lower spare respiratory capacity, which is expressed by the difference in maximal respiration after addition of carbonyl cyanide-ptrifluoromethoxyphenylhydrazone and respiration after addition of oligomycin (Supplementary figure 2a) .
One possible reason for a lowered SRC can be a reduced number of mitochondria.
11 Therefore, we determined the mitochondrial mass of MAIT cells compared to other T cell subsets, as well as their polarization status and functionality. Staining with MitoTracker Green revealed that MAIT cells have significantly lower mitochondrial content compared to T CM and T EM (Figure 1b) . This finding matches the tendency towards higher mitochondrial content seen in memory cell subsets 17 and was further supported by significant differences in mitochondrial mass between the different memory subsets in conventional "Non-MAIT" CD8 + T cells with T CM containing most mitochondria ( Figure 1b) . MAIT cells show a tendency towards a lower mitochondrial content than their T EM CD8 + counterparts and their mitochondrial mass was more comparable to the mitochondrial mass of na€ ıve (T N ) and terminally differentiated effector memory cells (T EMRA ) (Figure 1b) .
Depolarization of mitochondria was assessed by staining with MitoTracker DeepRed, which preferentially accumulates within healthy polarized mitochondria. 18, 19 MAIT cells showed similar mitochondrial depolarization compared to most CD8 + T cells ( 
Low production of reactive oxygen species and apoptosis and preserved autophagy in MAIT cells
Mitochondria are the most predominant cellular source of reactive oxygen species (ROS) and are involved in a major regulatory pathway of apoptosis induction. 21 Thus, we were interested in whether MAIT cells differ in the amount of ROS they produce and if they were more apoptotic compared to the other cell types. Using a dye that specifically stains for ROS produced in mitochondria, we observed that the ROS production in the MAIT cell population was overall lower compared to "Non-MAIT" CD8 + T cells (Figure 1f ). Looking at mitochondrial ROS production within "Non-MAIT" CD8 + T cells, T EMRA show the lowest amounts of mitochondrial reactive oxygen species. The frequency of apoptotic cells was by trend lowest in MAIT cells. Within "Non-MAIT" cells, T EM and T EMRA CD8 + T cells displayed a tendency toward higher apoptotic rates when stimulated with anti-CD3/CD28 (Supplementary figure  2c) .
Autophagy has been shown to be essential for the formation of memory CD8 + T cells 22 and constitutes an important cellular degradation pathway that recycles cellular content and can liberate metabolites for survival. 23 We observed that all CD8 + T cell subsets examined had increased frequencies of cells containing autophagic vacuoles upon stimulation. This was most pronounced in MAIT cells, T N and T CM (Supplementary figure 2d).
Analysis of glycolytic capacity in ex vivo MAIT cells
As glycolysis was also transcriptionally downregulated in resting CD161 ++ CD8 + T cells (Supplementary figure 1c) , we carried out a functional analysis examining glycolytic capacity in MAIT and "Non-MAIT" CD8 + T cells by Seahorse Glycolysis Stress Test. 16 Interestingly, the basal and maximal extracellular acidification rate was different between these two subsets (Figure 2a and Supplementary  figure 2a) . However, this difference was less pronounced compared to the difference in mitochondrial capacity of the two subsets. These findings are in line with a lower enrichment score in the glycolysis transcript set in CD161 À CD8 + T cells (Supplementary figure 1c) . We next investigated the cellular uptake of the fluorescent glucose analogue 2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose). Its uptake was comparable in all examined cell types, both in terms of frequency of 2-NBDG positive cells (Figure 2b ) and the median fluorescence intensity (Figure 2c ). There was no significant difference between MAIT cells and conventional T cells. Of these, T N showed the least capacity for glucose uptake compared to all other examined subsets (Figure 2b , c), consistent with previous reports. 17 
Upregulation of granzyme B in MAIT cells upon stimulation is dependent on glycolysis
Following optimal stimulation (TCR + cytokines), MAIT cells showed an increased uptake of the fluorescent glucose analogue 2-NBDG (Figure 2d ). This was most pronounced in MAIT cells as well as in only TCRstimulated T N and T CM CD8 + T cells. In contrast, in T EM and T EMRA no significant increase in glucose uptake was observed upon stimulation. The increased uptake of 2-NBDG in MAIT cells occurred in the presence of IL-12 and IL-18 alone, CD3/CD28-beads alone and synergistically in combination. After overnight stimulation and subsequent short-term incubation with 2-NBDG, most of the cells take up the fluorescent analogue independent of the cell type examined (data not shown). Thus, we decided to look at cells that take up high amounts of 2-NBDG (2-NBDG hi cells) within each subset. By doing so, we could again observe an increased uptake of glucose. In T N and T CM cells, uptake was mostly dependent on TCR stimulation and not affected by cytokine stimulation, whereas in MAIT cells we could ) AE anti-CD3/CD28. CD161 À cells were subdivided into T N , T CM , T EM and T EMRA . Significance was determined using paired, parametric twotailed t-test. Significance levels: * indicates P < 0.05, **P < 0.01, ***P < 0. ) AE anti-CD3/CD28. CD161 À cells were subdivided into T N , T CM , T EM and T EMRA . Significance was determined using a paired, parametric, two-tailed t-test. Significance levels: * indicates P < 0.05, **P < 0.01, ***P < 0.001. Error bars show mean AE s.d. Cumulative data are shown for n = 4 healthy donors (representative of two experiments).
observe an upregulation of glucose uptake upon cytokine stimulation alone (Figure 2e) . Stimulation of CD8 + T cells via the TCR leads to the initiation of effector functions and is dependent on the upregulation of glucose uptake. 24 We were thus interested in whether the increase in glucose uptake seen in MAIT cells correlated with enhanced upregulation of effector molecules. Indeed, after the stimulation of MAIT cells with cytokines, we observed an upregulation of granzyme B expression which was enhanced when both stimuli were combined (Figure 3a) . In contrast, granzyme B expression was not affected at all following stimulation in the other CD8 + T cell subsets (Figure 3b ). To further understand the role of glycolysis in an activated MAIT cell, the glucose analogue 2-deoxyglucose, which is able to inhibit the glycolytic pathways in T cells through the inhibition of the rate limiting enzyme hexokinase, was used. 25 We cultured cells in the presence of this agent and assessed the expression of granzyme B and CD69. A significantly lower expression of granzyme B was observed upon inhibition of the glycolytic pathway ( Figure 3a ) and we could show that this effect was dosedependent (Supplementary figure 3a) . In contrast, this was not the case in CD161 À CD8 + T cells and T cell subsets (Figure 3b and Supplementary figure 3b) . When we replaced glucose in the medium with equimolar ). Significance was determined using paired, parametric two-tailed t-test. Significance levels: * indicates P < 0.05, **P < 0.01, ***P < 0.001. Error bars show mean AE s. ). Significance was determined using a paired, parametric two-tailed t-test. Significance levels: * indicates P < 0.05, **P < 0.01, ***P < 0.001. Error bars show mean AE s.d. Data are shown for n = 3 healthy donors (representative of two independent experiments).
concentrations of galactose, we could not see a difference in upregulation of granzyme B despite galactose metabolism being transcriptionally enriched in CD161 ++ CD8 (Supplementary figures 1a, 3c) .
Furthermore, we observed an upregulation of the cellular activation marker CD69 in both MAIT cells and "Non-MAIT" CD8 + T cells which was predominantly dependent on stimulation of the T cell receptor (Figure 3c, d) . The expression of CD69 upon stimulation was not impaired by inhibiting glycolysis (Figure 3c, d) .
Taken together, these findings indicate that the upregulation of granzyme B in MAIT cells upon stimulation is dependent on the upregulation of the glycolytic pathway. This is similar to the increased effector functions seen in effector T cells with a corresponding initiation of glycolysis and inhibition of effector functions upon limiting glucose availability.
DISCUSSION
This study aimed to investigate the preferences of MAIT cells in their usage of metabolic pathways in a resting state and upon activation. We found that in the resting state, MAIT cells are metabolically quiescent, contain low levels of mitochondria, which are largely well-polarized. Examining their respiratory capacity using metabolic flux analysis, MAIT cells showed a lower potential for maximal respiration compared to "Non-MAIT" cells. It has been previously shown that T N had a lower SRC compared to T CM and T EM 26 and that this could be due to a reduced number of mitochondria.
11 Supporting this, Gene Set Enrichment Analysis revealed reduced expression of the oxidative phosphorylation gene set. Interestingly, the tendency toward more polarized and functional mitochondria, similar to what can be examined in T N and T CM , is in contrast to the distinct "effector-memory" profile of the MAIT cells in normal human blood.
Ex vivo, MAIT cells at a quiescent state consistently show a moderate amount of uptake of the fluorescent glucose analogue 2-NBDG. Metabolic flux analysis revealed that their basal and maximal extracellular acidification rates are lower compared to "Non-MAIT" CD8 + T cells. It has been previously shown that T N and T CM cells had a lower capacity for extracellular acidification compared to T EM and T EMRA.
26 Therefore, resting MAIT cells resemble the na€ ıve and central memory T cell subset in this respect, as well in functional responses-apoptosis and autophagy.
Glycolysis has been shown to be the predominant pathway used during T cell activation and effector function. 24 Similarly, once MAIT cells are activated they increase their uptake of the fluorescent glucose analogue 2-NBDG in a synergistic, stimulus dependent manner. The lowest uptake was observed with the combination of the cytokines IL-12 and IL-18, which increased with anti-CD3/CD28 stimulation and was synergistically increased upon combining these two stimuli. It has been reported before that MAIT cells show low granzyme B expression at a basal level but that its expression can be induced upon T cell receptor stimulation and co-culture with E. coli in a stepwise manner. 27 Granzyme B is a key protein for efficient cytotoxic activity and it accumulates in cytotoxic T cells following stimulation. Interestingly, it is not constitutively expressed upon stimulation in MAIT cells unlike other CD8 + T cell subsets. 27 Here, we provide further evidence that this process is likely dependent on a functioning glycolytic pathway as the upregulation of granzyme B was lost upon inhibition of glycolysis by 2-deoxyglucose. In this respect, MAIT cells behave in a similar manner to na€ ıve T cells which increase the use of their glycolytic pathway at their effector stage following antigen encounter. However, other effector functions of MAIT cells including the production of IFN-c, IL-17, perforin and TNF-a could be regulated independently from a functioning glycolytic pathway.
In summary, we have demonstrated a metabolic duality in MAIT cells. On the one hand they show characteristics of T CM and na€ ıve T cells at rest (in contrast to their T EM profile) but on the other hand they resemble effector T cells following stimulation. This mode of action may reflect their role at the bridge between innate and adaptive immunity. For comparison, human and murine NK cells show glycolysis-dependent functions including granzyme B upregulation 28 as do subsets of innate lymphoid cells (ILC2). 29 MAIT cells play an emerging role in different pathologies, with features similar to ILCs, NK cells and T cells in different settings. Furthermore definition of their metabolic traits in vivo, especially under conditions of inflammation and hypoxia could be of future interest including for therapeutic modulation of their functions.
METHODS Donors
Healthy donors were leukocyte cones (NHS Blood Services, Oxford, UK). All subjects were recruited in agreement with the local ethics committees of all participating institutions.
Microarray and gene set enrichment analysis
Cell sorting, RNA extraction and microarray analysis of CD161 + subsets within CD8 + T cells was performed as previously described.
Microarray data have been deposited on GEO under the series accession number GSE62099. A previously published dataset has been used for further comparisons (GSE23663). 14 Gene set enrichment analysis was performed using Broad Institute Software v3.0 (http://www.broadinstitute.org/gsea).
Flow cytometry and ICS
Staining with extracellular and intracellular markers are described in the Supplementary Information. 
In vitro metabolic assays
Statistical analysis
All graphs and statistical analysis were performed using Prism v7 (GraphPad Software Inc., San Diego, USA). Statistical significance was assessed using a one-way repeated measures ANOVA with Tukey's multiple comparison test or a paired t-test.
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